[Role of EZH2 Inhibitor Combined with Gefitinib in EGFR-TKIs Resistant Lung Cancer Cells].
Gong H, Yuan Y, Li Y, Zhang H, Li Y, Li W, Wang P, Shi R, Liu C, Cui L, Liu H, Chen J.
Gong H, et al. Among authors: yuan y.
Zhongguo Fei Ai Za Zhi. 2019 May 20;22(5):255-263. doi: 10.3779/j.issn.1009-3419.2019.05.01.
Zhongguo Fei Ai Za Zhi. 2019.
PMID: 31109434
Free PMC article.
Chinese.